These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 35807785)
21. Bioactivity of Two Polyphenols Quercetin and Fisetin against Human Gastric Adenocarcinoma AGS Cells as Affected by Two Coexisting Proteins. Wang B; Wang J; Zhao XH Molecules; 2022 Apr; 27(9):. PubMed ID: 35566228 [TBL] [Abstract][Full Text] [Related]
23. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. Yang PM; Tseng HH; Peng CW; Chen WS; Chiu SJ Int J Oncol; 2012 Feb; 40(2):469-78. PubMed ID: 21922137 [TBL] [Abstract][Full Text] [Related]
24. Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis. Kammerud SC; Metge BJ; Elhamamsy AR; Weeks SE; Alsheikh HA; Mattheyses AL; Shevde LA; Samant RS Lab Invest; 2021 Nov; 101(11):1439-1448. PubMed ID: 34267320 [TBL] [Abstract][Full Text] [Related]
25. Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways. Li Y; Jia S; Dai W Drug Des Devel Ther; 2020; 14():773-782. PubMed ID: 32158195 [TBL] [Abstract][Full Text] [Related]
26. A review on the chemotherapeutic potential of fisetin: In vitro evidences. Sundarraj K; Raghunath A; Perumal E Biomed Pharmacother; 2018 Jan; 97():928-940. PubMed ID: 29136771 [TBL] [Abstract][Full Text] [Related]
27. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways. Zhang XJ; Jia SS Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764 [TBL] [Abstract][Full Text] [Related]
28. Anticancer Potential of Selected Flavonols: Fisetin, Kaempferol, and Quercetin on Head and Neck Cancers. Kubina R; Iriti M; Kabała-Dzik A Nutrients; 2021 Mar; 13(3):. PubMed ID: 33807530 [TBL] [Abstract][Full Text] [Related]
29. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21 Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393 [TBL] [Abstract][Full Text] [Related]
30. New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells. Rzeszutek I; Cybularczyk-Cecotka M; Deręgowska A; Stec P; Wnuk M; Kołodziej O; Kałafut J; Wawruszak A; Witkowski W; Litwinienko G; Lewińska A J Med Chem; 2024 Oct; 67(19):17676-17689. PubMed ID: 39322603 [TBL] [Abstract][Full Text] [Related]
31. Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways. Rahmani AH; Almatroudi A; Allemailem KS; Alwanian WM; Alharbi BF; Alrumaihi F; Khan AA; Almatroodi SA Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298616 [TBL] [Abstract][Full Text] [Related]
32. Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter. Kim JA; Lee S; Kim DE; Kim M; Kwon BM; Han DC Carcinogenesis; 2015 Jun; 36(6):696-706. PubMed ID: 25840992 [TBL] [Abstract][Full Text] [Related]
33. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models. Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422 [TBL] [Abstract][Full Text] [Related]
34. Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells. Kim N; Lee SH; Son JH; Lee JM; Kang MJ; Kim BH; Lee JS; Ryu JK; Kim YT Anticancer Res; 2016 Nov; 36(11):6109-6116. PubMed ID: 27793939 [TBL] [Abstract][Full Text] [Related]
35. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Suh Y; Afaq F; Johnson JJ; Mukhtar H Carcinogenesis; 2009 Feb; 30(2):300-7. PubMed ID: 19037088 [TBL] [Abstract][Full Text] [Related]
36. Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models. Sechi M; Lall RK; Afolabi SO; Singh A; Joshi DC; Chiu SY; Mukhtar H; Syed DN Sci Rep; 2018 Oct; 8(1):15726. PubMed ID: 30356079 [TBL] [Abstract][Full Text] [Related]
37. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells. Sundarraj K; Raghunath A; Panneerselvam L; Perumal E Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424 [TBL] [Abstract][Full Text] [Related]
38. Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature. Crocetto F; di Zazzo E; Buonerba C; Aveta A; Pandolfo SD; Barone B; Trama F; Caputo VF; Scafuri L; Ferro M; Cosimato V; Fusco F; Imbimbo C; Di Lorenzo G Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836005 [TBL] [Abstract][Full Text] [Related]
39. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Szliszka E; Helewski KJ; Mizgala E; Krol W Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964 [TBL] [Abstract][Full Text] [Related]
40. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells. Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]